Posts filed under: Orthopedic Biomaterials

Register to receive a free Orthopedic Biomaterials Market Report Suite for US 2017-2023 synopsis and brochure Biotechnology startup Molecular Matrix Inc. has received 510(k) FDA clearance for a carbohydrate-based polymer that can help injured bones heal and regrow, reports the University of...
Continue Reading →
Anika Therapeutics, Inc., a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, recently announced that its HA-based bone void filler received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and...
Continue Reading →
These newly introduced products join Trabexus EB, which first received 510(k) clearance in 2015. TRABEXUS EB is a self-setting, gradually resorbable, calcium phosphate matrix enhanced with partially demineralized allograft particles....
Continue Reading →
Bone graft substitutes are widely used in a variety of indications, including dental, spine, trauma, large joint, foot & ankle, craniomaxillofacial, and oncology....
Continue Reading →
  • Bone growth medical product
Firm wants data on best dosage of controversial bone-growth product. ...
Continue Reading →
The U.S. orthopedic biomaterials market is expected to increase to exceed $4.5 billion by 2023...
Continue Reading →
By Payam Moghimi-Bidhendi and Jesse Spicer – iData Research Inc. The European orthopedic biomaterials market is broadly driven by the aging population and for being an attractive alternative for patients looking to avoid surgical implantation of permanent devices or hardware....
Continue Reading →
This price deterioration will have a negative impact on the market, as it may not be economically feasible for certain competitors to penetrate the European market with low average selling prices...
Continue Reading →
NovaBone Products, a leading biologics medical device company, recently announced the addition of NovaBone IRM and NovaBone IRM MacroPOR to its portfolio of biologically active bone graft substitutes....
Continue Reading →
By Payam Moghimi-Bidhendi and Kamran Zamanian, Ph.D, iData Research Inc Introduction The U.S. orthopedic biomaterials market has become an attractive alternative for patients looking to avoid surgical implantation of permanent devices or hardware. Orthopedic surgeries are generally complicated, multi-stage procedures...
Continue Reading →

Thank you!

CLOSE

Login

Sign Up


Already have an account? Sign in

×